The Prevalence of Polycystic Ovary Syndrome (PCOS) in High School Students in Rasht in 2009 According to NIH Criteria

Overview

Journal Int J Fertil Steril

Specialty Reproductive Medicine

Date 2014 May 23

PMID 24851175

Citations 12

Authors

Maryam Asgharnia

Fariba Mirblook

Mitra Ahmad Soltani

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women associated with many reproductive, endocrine, metabolic and cardiovascular dysfunctions. This study aimed to determine the prevalence of PCOS among high school students in Rasht.

Materials And Methods: In a cross-sectional study, 1850 students were selected by a multi-stage cluster sampling from all high schools in Rasht. The inclusion criteria were: age 17-18 years, menarche from 10-16 years, normal prolactin and thyroid stimulating hormone (TSH) values, no history of anatomical malformation, no use of medication or hair-removal techniques, and a history of oligo- or amenorrhea. PCOS was diagnosed if both menstrual dysfunction and clinical hyperandrogenism were detected.

Results: Mean age of subjects was 17.2 ± 0.7 years and the age of menarche was 12.8 ± 0.9 years. Of all students, 378 (20.4%) had oligomenorrhea and PCOS was diagnosed in 210 (11.34 %) according to the National Institute of Health (NIH) definition. PCOS subjects, mean body mass index (BMI), waist circumference, and waist/hip (W/H) ratio were 21.1 ± 3.6, 73.4 ± 8.0 cm and 0.77 ± 0.05, respectively. A family history of diabetes mellitus type 2 was reported in 24.7% of subjects.

Conclusion: The prevalence of PCOS in this study was similar to the international estimates of 10-20% in Caucasians. A long-term follow-up is needed to compare the accuracy of clinical determination of the disease versus diagnosis based on hormonal and/or sonographic assessments.

Citing Articles

Visfatin and VEGF levels are not increased in adolescent girls with polycystic ovary syndrome.

Skrzynska K, Zachurzok A, Pietrusik A, Jakubowska-Kowal K, Gawlik-Starzyk A Front Endocrinol (Lausanne). 2024; 15:1488249.

PMID: 39600944 PMC: 11588468. DOI: 10.3389/fendo.2024.1488249.

Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis.

Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S Arch Gynecol Obstet. 2024; 310(3):1303-1314.

PMID: 38922413 DOI: 10.1007/s00404-024-07607-x.

A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students.

Coffin T, Wray J, Sah R, Maj M, Nath R, Nauhria S Cureus. 2023; 15(6):e40141.

PMID: 37304389 PMC: 10256275. DOI: 10.7759/cureus.40141.

Prevalence of Polycystic Ovary Syndrome in Iranian Adolescent Girls Based on Adults and Adolescents' Diagnostic Criteria in Mashhad City.

Pourhoseini S, Babazadeh R, Mazlom S J Reprod Infertil. 2022; 23(4):288-295.

PMID: 36452191 PMC: 9674463. DOI: 10.18502/jri.v23i4.10815.

Prevalence of Common Gynecological Conditions in the Middle East: Systematic Review and Meta-Analysis.

Mousa M, Al-Jefout M, AlSafar H, Kirtley S, Lindgren C, Missmer S Front Reprod Health. 2022; 3:661360.

PMID: 36304010 PMC: 9580651. DOI: 10.3389/frph.2021.661360.

References

van Hooff M, Voorhorst F, Kaptein M, HiraSing R, Koppenaal C, Schoemaker J . Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents. Hum Reprod. 1999; 14(9):2223-9. DOI: 10.1093/humrep/14.9.2223. View

Hammer L, Kraemer H, Wilson D, Ritter P, Dornbusch S . Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child. 1991; 145(3):259-63. DOI: 10.1001/archpedi.1991.02160030027015. View

Ludwig E . Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977; 97(3):247-54. DOI: 10.1111/j.1365-2133.1977.tb15179.x. View

Knochenhauer E, Key T, Kahsar-Miller M, Waggoner W, Boots L, Azziz R . Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998; 83(9):3078-82. DOI: 10.1210/jcem.83.9.5090. View

Franks S . Polycystic ovary syndrome in adolescents. Int J Obes (Lond). 2008; 32(7):1035-41. DOI: 10.1038/ijo.2008.61. View

Gordon C . Menstrual disorders in adolescents. Excess androgens and the polycystic ovary syndrome. Pediatr Clin North Am. 1999; 46(3):519-43. DOI: 10.1016/s0031-3955(05)70135-8. View

Hatch R, Rosenfield R, Kim M, Tredway D . Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981; 140(7):815-30. DOI: 10.1016/0002-9378(81)90746-8. View

Coviello A, Legro R, Dunaif A . Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2005; 91(2):492-7. DOI: 10.1210/jc.2005-1666. View

Diamanti-Kandarakis E, Kouli C, Bergiele A, Filandra F, Tsianateli T, Spina G . A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999; 84(11):4006-11. DOI: 10.1210/jcem.84.11.6148. View

10.

van Hooff M, Voorhorst F, Kaptein M, HiraSing R, Koppenaal C, Schoemaker J . Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril. 2000; 74(1):49-58. DOI: 10.1016/s0015-0282(00)00584-7. View

11.

Lookingbill D, Demers L, Wang C, Leung A, Rittmaster R, Santen R . Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab. 1991; 72(6):1242-8. DOI: 10.1210/jcem-72-6-1242. View

12.

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19-25. DOI: 10.1016/j.fertnstert.2003.10.004. View

13.

Driscoll D . Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci. 2003; 997:49-55. DOI: 10.1196/annals.1290.006. View

14.

Allen S, POTTER H, Azziz R . Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women. Fertil Steril. 1997; 67(3):569-72. DOI: 10.1016/s0015-0282(97)80089-1. View

15.

GIVENS J . Ovarian hyperthecosis. N Engl J Med. 1971; 285(12):691. View

16.

Asuncion M, Calvo R, San Millan J, Sancho J, Avila S, Escobar-Morreale H . A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000; 85(7):2434-8. DOI: 10.1210/jcem.85.7.6682. View

17.

Solomon C . The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am. 1999; 28(2):247-63. DOI: 10.1016/s0889-8529(05)70069-4. View

18.

Franks S, McCarthy M, Hardy K . Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl. 2006; 29(1):278-85. DOI: 10.1111/j.1365-2605.2005.00623.x. View

19.

Battaglia C, Regnani G, Petraglia F, Primavera M, Salvatori M, Volpe A . Polycystic ovary syndrome: it is always bilateral?. Ultrasound Obstet Gynecol. 1999; 14(3):183-7. DOI: 10.1046/j.1469-0705.1999.14030183.x. View

20.

Abbott D, Dumesic D, Franks S . Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol. 2002; 174(1):1-5. DOI: 10.1677/joe.0.1740001. View